Determination of Antibiotic Susceptibility Pattern of Clinical Isolates of Salmonella Typhi and Escherichia Coli
Annals of Reviews and Research Research Article Ann Rev Resear Volume 2 Issue 5 - August 2018 Copyright © All rights are reserved by Muhammad Ali Determination of Antibiotic Susceptibility Pattern of Clinical Isolates of Salmonella Typhi and Escherichia Coli Farouk Nas S1, Musa Diso AA2, Idris IS3 and Muhammad Ali4* 1Department of Biological Science, Bayero University, Nigeria 2Department of Science Laboratory Technology, School of Technology, Nigeria 3Department of Pharmaceutical Technology, School of Technology, Nigeria 4Microbiology Department, Kano University of Science and Technology, Nigeria Submission: June 21, 2018; Published: August 08, 2018 *Corresponding author: Muhammad Ali, Microbiology Department, Kano University of Science and Technology Wudil, Kano, Nigeria, Tel: 2347032967252, Email: Abstract The aim of the study is to determine the antibiotic sensitivity pattern of clinical isolates of Salmonella typhi and Escherichia coli. The isolates test.were The obtained sensitivity from patternstool sample of Salmonella of typhoid typhi fever and patients Escherichia attending coli was Muhammad tested against Abdullahi commercially wase Specialist prepared Hospital antibiotics Kano. sensitivity Identification disc ofusing the bacterial isolates was done using conventional standard laboratory methods including Gram staining, culturalSalmonella characterization typhi was and susceptible biochemical to andKirby-Bauer Nalidixic method. acid is intermediate. Based on the On finding the other of this hand, study, Escherichia most of the coli antibiotics were found are resistant active against to Augmentin, the isolates. Ceporex and Ampicillin while sensitive Travid, Reflacin, Ciprofloxacin, Streptomycin and Gentamicin but resistance to Ampicillin. However, its sensitivity to Septrin Augmentin, Ceporex to Reflacin, Taravid, Septri and Streptomycin while Escherichia coli were found intermediate sensitive to Ciprofloxacin and Gentamicin.
[Show full text]